Chambel et al. indicated that activated NRF2 inhibited lipid accumulation in white adipose tissue, limited adipogenesis, induced insulin resistance and glucose intolerance, and increased hepatic steatosis in ob/ob mice [92]. The gene discussed is NFE2L2; the disease is Hepatic steatosis.